Navigation Links
Lymphoma Research Foundation announces publication of Mantle Cell report
Date:2/9/2010

Highlights from the Lymphoma Research Foundation (LRF) 2009 Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop will be published in the March 2010 issue of Leukemia & Lymphoma. Traditionally accessible to subscribers for period of one year, Leukemia and Lymphoma has agreed to make this report available to the public for one month -- Mantle Cell Lymphoma: Report of the 2009 MCL Consortium Workshop.

"It is gratifying to see our work recognized by a respected scientific journal such as Leukemia & Lymphoma. We hope the information published in this report will further accelerate the understanding of mantle cell lymphoma and encourage other researchers to seek out collaborative work environments such as LRF's Mantle Cell Lymphoma Consortium,' commented Michael Williams, MD, MCLC Chairman and Director, Hematologic Malignancy Program Hematology/Oncology Division University of Virginia Health System, Charlottesville..


'/>"/>

Contact: Marion F. Swan
mswan@lymphoma.org
212-349-6435
Lymphoma Research Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. New treatment approach promising for lymphoma patients in the developing world
2. Galiximab in combination with rituximab in patients with previously untreated follicular lymphoma
3. Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
4. Research could lead to way to halt deadly immune response
5. Scripps research team reveals how an old drug could have a new use for treating river blindness
6. New era of pain drugs advanced by Barrow researcher
7. Research identifies gene with likely role in premenstrual disorder
8. Researchers reveal 3-D structure of bullet-shaped virus with potential to fight cancer, HIV
9. Autism Speaks presents the top ten autism research findings of 2009
10. S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now?
11. Research reveals link between beer and bone health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a ... point-of-care products for the objective detection of concussion and ... company has successfully completed a meeting with the U.S. ... Tbit™ blood test Pre-Submission Package. During the meeting company ... system as a precursor to commencement of a planned ...
(Date:11/24/2016)... 2016 Cercacor today introduced Ember TM ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, ... Rate in approximately 30 seconds. Smaller than a smartphone, ... access to key data about their bodies to help ... Hemoglobin carries oxygen to muscles. When ...
Breaking Biology News(10 mins):
(Date:12/7/2016)...  Vyriad Inc. announced today the appointment of ... Directors. "We are delighted to welcome Al ... develop our oncolytic viruses as the next generation of ... , MD, PhD, CEO of Vyriad. "Al and his ... passion for making a difference for cancer patients—their philanthropy ...
(Date:12/7/2016)... Texas , Dec. 7, 2016  Genprex, ... of revolutionary immunogene therapy treatments, today announced that ... practice within a leading strategic communications and advisory ... communications program. The program will combine investor relations, ... objective of raising the profile of Genprex and ...
(Date:12/7/2016)... BOULDER, Colo. , Dec. 7, 2016  Muse ... genome engineering technologies, today announced that Dr. Kevin ... member of the Board of Directors. ... , who becomes the company,s Chief Science Officer as ... and Executive Director of the BioDesign Center at the ...
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, 2016 /PRNewswire/ ... immune modulatory medicines, announced today the initiation of a ... candidate, LYC-30937- E nteric C oated, in patients ... that is estimated to affect as many as 7.5 million ... with approximately 1.5 - 3 million cases being diagnosed ...
Breaking Biology Technology: